National Medical Insurance Bureau: On average, 116 drugs per province will be reduced in price, affecting all pharmacies

The National Medical Insurance Administration said that in 2022, an average of 116 medicines in each province will have their prices reduced, which will affect all pharmacies across the country
.

In 2022, the average price of 116 medicines in each province will be reduced

In 2022, the average price of 116 medicines in each province will be reduced

According to Xinhua News Agency, the National Medical Insurance Bureau recently stated that it will strive to achieve an average of more than 350 drug varieties per province by the end of 2022 through national organizations and provincial alliance procurement
.

At present, the country has carried out six batches of centralized procurement with volume, and the number of purchased drugs has reached 234, with an average price reduction of 53%

This news means that by the end of this year, each province in the country will add an average of 116 new varieties of centralized drugs
.

For pharmacies across the country, another large number of drugs ushered in a "price reduction"

It is worth mentioning that the national "14th Five-Year Plan for National Medical Insurance" clearly states that by 2025, more than 500 varieties of national and provincial drugs will be purchased in a centralized manner in each province
.

The National Medical Insurance Bureau now requires that there will be an average of more than 350 varieties of centralized procurement per province in 2022, and it will take two years to reach 70% of the progress of the five-year plan, and the speed of centralized drug procurement will be significantly accelerated

Chen Jinfu, deputy director of the National Medical Security Administration, said that over the past three years, the state-organized centralized procurement has saved more than 260 billion yuan in costs, and the price of drugs has remained stable with some declines.
State-organized and alliance procurement has become a normalized pattern
.

It can be seen from the above that with the normalization of centralized drug procurement, more and more drugstores will significantly reduce the price of drugs
.

In the era of centralized procurement, pharmaceutical companies "send" gross profits

In the era of centralized procurement, pharmaceutical companies "send" gross profits

In the era of centralized purchasing, pharmacies sacrificed gross profits, but some pharmaceutical companies "send" gross profits
.

It is worth noting that some domestic pharmaceutical companies that have not entered the centralized procurement market are making efforts in the pharmacy terminal market.
In cooperation with pharmacies, they usually bring high gross profits to the pharmacies
.

Taking the first batch of centralized lipid-lowering drug "Rosuvastatin Calcium" as an example, the original manufacturer, AstraZeneca, was unsuccessful in the pharmacy retail market
.

According to Zhongkang CMH data, in the first quarter of 2020, the sales of AstraZeneca's rosuvastatin calcium in the pharmacy market reached 410 million yuan, an increase of nearly 70% compared to the same period in 2019

Xie Zilong, chairman of the common people, said at the 2020 annual shareholders meeting that centralized procurement is more beneficial to the pharmacy chain industry, because pharmaceutical companies that have not entered the centralized procurement will be more inclined to choose to cooperate with pharmacies.
This business brings benefits to the company.
The gross profit margin will be relatively higher
.

He Gan, general manager of the People's Prescription Drug Purchasing Center, said at the 2020 SIP Conference that drug prices have fallen sharply, hospital pharmacies have changed from a profit segment to a cost segment, and hospitals have gradually changed their attitude towards prescription outflow, giving retail pharmacies opportunities to undertake
.

"Pharmacy into centralized purchase" has become a national trend

"Pharmacy into centralized purchase" has become a national trend

After sorting out, it is found that many places are accelerating the process of "pharmacies entering centralized procurement" recently, and "pharmacies entering centralized procurement" has become a major trend across the country
.

In October 2021, Luzhong.
com reported that after Zibo City, Shandong launched the "Nationally-sourced Drugs into Pharmacies", the city's pharmacies' average passenger flow increased by more than 20%, and the average sales volume exceeded 40%
.

In the same month, Shandong, Guangdong, Hebei, Henan, Hubei and other provinces issued the fifth batch of centralized procurement drug landing notices, saying that designated pharmacies should be included in the centralized procurement executive agencies
.

In December 2021, the person in charge of the Henan Medical Insurance Bureau clearly stated that this spring, the province will launch a pilot program of "the first batch of pharmacies to sell centralized medicines"

What needs to be mentioned is that the pilot program of “pharmacy sales centralized drug collection” in Henan is quite large.

A local pharmacy owner in Henan said that in addition to the best-selling drugs in pharmacies, the centralized procurement pilot also includes many types of hospitals with high traffic flow.

Some people in the industry believe that if the scale of pharmacies is limited, it is actually difficult to enjoy the dividends of centralized procurement.